医学
血栓形成
血小板
重症监护医学
血管闭塞
止血
心脏病学
内科学
血小板活化
生物信息学
免疫学
生物
作者
Milka Koupenova,Beate E. Kehrel,Heather A. Corkrey,Jane E. Freedman
标识
DOI:10.1093/eurheartj/ehw550
摘要
Haemostasis and thrombosis are complex, multifactorial processes. There is an evolving understanding of the mechanisms influencing vascular occlusion and the role of inflammation and immunity. Despite major advances in elucidating the mechanistic pathways mediating platelet function and thrombosis, challenges in the treatment of vascular occlusive diseases persist. Pharmacological advances have greatly affected thrombotic outcomes, but this has led to the unwanted side effect of bleeding. Detailed assessment of the impact of non-thrombotic diseases on haemostasis and thrombosis is necessary to better evaluate thrombotic risk and establish optimal treatment. This review will focus on recent advances in understanding the contribution of evolving risk factors to thrombosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI